Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis (The LASER-TBM Trial)

medRxiv(2022)10.1101/2022.07.26.22278065Source: DataRank Database

A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis (The LASER-TBM Trial) is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (15)IDs (PubMed, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (32)

Sean Wasserman ORCID,Cari Stek ORCID,Mpumi Maxebengula,Chen Liang ORCID,Stephani Stegmann

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W4288074911

Wellcome Trust

Grant: 175479

Wellcome Trust

Grant: 214321/Z/18/Z

greenLicense: cc-by

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/07/26/2022.07.26.22278065.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.07.26.22278065

repositoryhttps://doi.org/10.1101/2022.07.26.22278065

Europe_PMChttps://europepmc.org/article/PPR/PPR524607

Fields of Study

Infectious Diseases and TuberculosisOrthopedic Infections and TreatmentsPneumocystis jirovecii pneumonia detection and treatment

Keywords

MedicineLinezolidContext (archaeology)TolerabilityRifampicinAspirinAdverse effectRandomized controlled trialInternal medicineSurgeryTuberculosisVancomycin

Sustainable Development Goals

SDG 0: Good health and well-being

A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis (The LASER-TBM Trial)

FAIR Checklist

Authors (32)

Funding (2 grants)

Open Access

Topics

Annotations (Europe PMC)